Metropolis Healthcare launches blood-based test for early Alzheimer’s detection
New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines
New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
Roche also shared the design of its upcoming Phase III TRONTIER 1 and 2 trials investigating trontinemab in people with early symptomatic Alzheimer’s disease
Subscribe To Our Newsletter & Stay Updated